Companies / Pyxis Oncology, Inc.

Pyxis Oncology, Inc.

Nasdaq: PYXSCIK 1782223BOSTON, MA

Financials · FY2025

Revenue$13.86M
Net income$-79.62M
Total debt—
Cash$18.86M
Diluted EPS$-1.28
Shares outstanding83.4M

Ownership

83.4M shares outstanding · as of Aug 12, 2026
0.71%Insiders
Ownership
Insiders0.71%594,191
Institutions35.38%29,508,175
Public float63.91%53,305,684

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Wadhane JitendraPrin Fin & Acct Officer
0.61%512,882
Humphrey RachelDirector
0.10%81,309
Civik ThomasCEOInterim CEO · Director
——
Cline Darren SDirector
——
Dupont JakobDirector
——
Flavin John LDirector
——
Lewis-Hall Freda CDirector
——
Metzger Michael ADirector
——
Palani SanthoshDirector
——

Institutional holders 80

View all →
HolderValue% of shares
Pfizer Inc$8.09M8.43%
Laurion Capital Management LP$7.30M5.99%
GordonMD Global Investments LP$4.74M4.94%
Vanguard Group Inc$2.69M2.80%
BlackRock, Inc.$2.61M1.04%
Atle Fund Management AB$1.62M0.24%
Palo Alto Investors LP$1.48M1.21%
Renaissance Technologies LLC$1.30M1.07%
683 Capital Management, LLC$1.03M1.07%
Jane Street Group, LLC$903.9K0.94%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 21, 2025Humphrey Rachel
Director
SellCommon Stock$14.4K-14K
-14.60%
81,309
0.10% of shares
low
Apr 14, 2025Humphrey Rachel
Director
SellCommon Stock$1.4K-1K
-1.45%
95,405
0.11% of shares
low
Apr 17, 2025Humphrey Rachel
Director
SellCommon Stock$194-200
-0.21%
95,205
0.11% of shares
low
Mar 24, 2026Wadhane Jitendra
Executive
GrantCommon Stock$0+109K
+27.13%
512,882
0.61% of shares
low
Mar 24, 2026Dupont Jakob
Director
GrantStock Option (Right to Buy)—+46K
45,867
0.05% of shares
low
Mar 24, 2026Wadhane Jitendra
Executive
GrantStock Option (Right to Buy)—+263K
262,635
0.31% of shares
low
Mar 24, 2026Flavin John L
Director
GrantStock Option (Right to Buy)—+46K
45,867
0.05% of shares
low
Mar 24, 2026Metzger Michael A
Director
GrantStock Option (Right to Buy)—+46K
45,867
0.05% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Laurion Capital Management LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PYXSCommon StockEquity747324101BBG00PQFFCV5